Subtype-Specific Counseling for Thyroid Cancer Patients Patients with papillary, follicular, or Oncocytic (Hrthle cell) thyroid cancer should not be told or assume that GLP-1 therapy caused their disease in the absence of supporting evidence
Recent Developments: In 2025 , Eli Lilly and Company received FDA approval for tirzepatide (Zepbound) for the treatment of obstructive sleep apnea in adults with obesity, expanding its therapeutic applications beyond metabolic disorders
Proven Global Export Track Record Our company has made a strong presence in 10+ countries, including markets in Asia, Africa, and many more
El Khoudary, S.R., Aggarwal, B., Beckie, T.M., Hodis, H.N., Johnson, A.E., Langer, R.D., Limacher, M.C., Manson, J.E., Stefanick, M.L., & Allison, M.A
Tous les traitements en cours, contraception comprise, doivent tre signals aux mdecins intervenants